Cheng Wang
Leah E. Latham1
Tucker A. Patterson
Fang Liu- 1Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, AR, United States
- 2Office of Center Director, National Center for Toxicological Research/Food and Drug Administration (FDA), Jefferson, AR, United States
- 3Office of Pharmaceutical Quality, Center for Drug Evaluation and Research/FDA, Silver Spring, MD, United States
Abstract
Safety concerns about general anesthetics (GA), such as desflurane (a commonly used gaseous anesthetic agent), arose from studies documenting neural cell death and behavioral changes after early-life exposure to anesthetics and compounds with related modes of action. Neural stem cells (NSCs) can recapitulate most critical events during central nervous system (CNS) development in vivo and, therefore, represent a valuable in vitro model for evaluating potential desflurane-induced developmental neurotoxicity. In this study, NSCs harvested from the hippocampus of a gestational day 80 monkey brain were applied to explore the temporal relationships between desflurane exposures and neural stem cell health, proliferation, differentiation, and viability. At clinically relevant doses (5.7%), desflurane exposure did not result in significant changes in NSC viability [lactate dehydrogenase (LDH) release] and NSC proliferation profile/rate by Cell Cycle Assay, in both short term (3 h) and prolonged (24 h) exposure groups. However, when monkey NSCs were guided to differentiate into neural cells (including neurons, astrocytes, and oligodendrocytes), and then exposed to desflurane (5.7%), no significant changes were detected in LDH release after a 3-h exposure, but a significant elevation in LDH release into the culture medium was observed after a 24-h exposure. Desflurane (24 h)-induced neural damage was further supported by increased expression levels of multiple cytokines, e.g., G-CSF, IL-12, IL-9, IL-10, and TNF-α compared with the controls. Additionally, our immunocytochemistry and flow cytometry data demonstrated a remarkable attenuation of differentiated neurons as evidenced by significantly decreased numbers of polysialic acid neural cell adhesion molecule (PSA-NCAM)-positive cells in the desflurane-exposed (prolonged) cultures. Our data suggests that at the clinically relevant concentration, desflurane did not induce NSC damage/death, but impaired the differentiated neuronal cells after prolonged exposure. Collectively, PSA-NCAM could be essential for neuronal viability. Desflurane-induced neurotoxicity was primarily associated with the loss of differentiated neurons. Changes in the neuronal specific marker, PSA-NCAM, may help understand the underlying mechanisms associated with anesthetic-induced neuronal damage. These findings should be helpful/useful for the understanding of the diverse effects of desflurane exposure on the developing brain and could be used to optimize the usage of these agents in the pediatric setting.
Introduction
While controversial, it is suspected that extended or multiple early-life exposures to general anesthetics may lead to later adverse cognitive development [1–8]. However, it remains uncertain if the neurodevelopmental deficits are caused by general anesthesia, the surgery/procedure used to treat the condition, or the condition itself [9, 10]. All approved general anesthetics including desflurane, have NMDA-type glutamate receptor-blocking or GABAA receptor-enhancing properties. Desflurane belongs to the group of medicines known as general anesthetics. Inhaled desflurane is used to cause general anesthesia (loss of consciousness) before and during surgery in adults. It is also used as a maintenance anesthesia in adults and children after receiving other anesthetics before and during surgery. Available findings indicate that decreased excitation of NMDA receptors or increased activation of GABAA receptors can induce wide-spread neurodegeneration in the developing rodent or monkey brain [11–14] and cause cognitive impairments [15–17]. Additionally, a population-based study showed that early exposure to anesthesia could be a significant risk factor for later learning disabilities [1]. Appropriate studies performed have not demonstrated pediatric-specific problems that would limit the usefulness of inhaled desflurane [18] in children after receiving other anesthetics. However, children 6 years of age and younger are more likely to have unwanted side effects, such as coughing, chest tightness, or trouble breathing, which may require caution in patients receiving this agent. Previous studies have demonstrated that exposure of the developing brain to gaseous anesthetics such as nitrous oxide plus isoflurane during the period of synaptogenesis produced exposure duration-dependent increases in neurotoxicity [4, 7, 8, 12, 19] and lasting behavioral changes [6, 16]. A growing body of data indicates that prolonged bouts of anesthesia in the developing brain may lead to neurodegeneration. It is proposed that anesthetic-induced neurotoxicity depends upon the concentration of drug used, the duration of exposure, and the age of neurodevelopment at the time of exposure [12].
Most nonclinical models of neurotoxicity rely on animals, however, some in vitro models [11, 13, 20, 21] have emerged that can provide similar data. Particularly, NSC models [14] with their capacity to reproduce the most critical developmental processes including proliferation and differentiation, may serve as an effective alternative when evaluating anesthesia-related neurotoxicity. Since nonhuman primates have a central nervous system comparable to humans relative to anatomy, physiology and development, monkey NSCs [21, 22] can reach a high degree of concordance. Thus, the utilization of highly relevant in vitro monkey NSC models, might serve as a “bridging” system to evaluate the cellular and molecular changes after anesthetic exposure. Translational observations could also be made by exploring issues related to pediatric desflurane exposure from nonhuman primate neural stem cells, thereby providing valuable information on the ability to better interrogate specific mechanisms and the ability to do large scale of science research that cannot easily occur in vivo.
The neural cell adhesion molecule (NCAM) serves as a temporally and spatially regulated modulator of a variety of cell-cell interactions. It is known that cells expressing polysialylated isoforms of NCAM (PSA-NCAM) have a markedly increased capacity for structural plasticity [23–25], and the polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation [26]. Meanwhile, as a neuronal specific marker, PSA-NCAM has been used to identify/define developing neurons [21, 25, 27].
For this study, it was hypothesized that: 1) NSCs from nonhuman primates (NHP) could recapitulate key findings from in vivo work that support “clinical-like” studies in the NHP; 2) desflurane-induced neural damage, if any, most likely depends on the duration of exposure; 3) desflurane-induced neural damage/neuronal-loss could be evaluated using biological assays and monitoring PSA-NCAM expression levels; and 4) measuring PSA-NCAM levels could serve as a key step (as a target molecule) to dissect the underlying mechanisms associated with anesthetic-induced neurotoxicity.
Materials and methods
Test agents
Desflurane was purchased from NexAir, LLC (Memphis, TN). Desflurane (5.7%) was driven by the delivery gas (mixed gas) of 21% oxygen, 5% CO2, and balanced by nitrogen.
Cultures
Media for NSC proliferation (named “growth medium”) and for NSC differentiation (named “differentiation medium”) were purchased from VESTA Biotherapeutics (Branford, CT). Monkey NSCs were harvested from the gestational day 80 fetal monkey [28]. The cells were seeded on poly-D-lysine/laminin-coated dishes. Monkey NSCs were cultured in NSC growth medium [Vesta Biotherapeutics; Branford, CT (changed every 48 h)] until the cells reached confluence. The cells were then transferred to 35 mm Petri dishes (Corning Incorporated; Corning, NY) with round cover slips at a seeding density of 6 × 103 cells/cm2, and 24 h after seeding the cells were used for NSC characterization, and/or were directed to differentiate using neural differentiation medium (Vesta Biotherapeutics; Branford, CT) for another 5 days, with culture medium changed every other day. The cells were cultured in a standard culture incubator with humidified air and 5% carbon dioxide at 37°C. The concentrations of oxygen and carbon dioxide in the chamber were continuously monitored.
To expose to desflurane, the cells/cultures were loaded into a VitroCell System (VITROCELL Systems GmbH; Waldkirch, Germany) where the concentrations of desflurane, oxygen, and carbon dioxide (CO2) were accurately maintained during the experiment. Control cultures were also loaded to the same system without exposure to desflurane.
5-ethynyl-2′-deoxyruidine (EdU) incorporation assay
The NSC proliferation rate was measured using an EdU staining kit [Click-iT® EdU Alexa Fluor® High-throughput Imaging (HCS) Assay, Invitrogen; Carlsbad, CA] as previously described [13, 14].
Cell cycle
NSCs were detached and washed twice in cold PBS and centrifuged at 200 g for 5 min at 4°C. Cells were fixed in 70% ethanol for 1 h on ice. Cells were washed and treated with 0.25 mg/mL RNase (Qiagen) for 1 h at 37°C. Cells were then immediately stained with 10 μg/mL propidium iodide (PI; Millipore; Burlington, MA) for 30 min on ice. Samples were run on a BD LSR Fortessa flow cytometer and at least 100,000 events were captured. Cells were analyzed for PI positivity using FCS Express version 6 (De Novo Software).
Assessment of neurotoxicity
Lactate dehydrogenase (LDH) release
The release of LDH into the culture medium occurs with loss of plasma membrane integrity, a process most often associated with acute cell death. The LDH (Roche Applied Science; Indianapolis, IN) release assay was performed as previously reported [20, 29] to determine cytotoxicity after desflurane exposure.
Cytokine immunoassay
Cell lysate was collected from NSCs after exposure to desflurane or delivery of mixed air (control) using the Bio-Plex Cell Lysis kit (Bio-Rad; Kansas City MO) and protein concentration was measured by the DC Protein Assay kit (Bio-Rad; Kansas City MO). Cell lysates were then probed with cytokines and growth factors using the Bio-Plex Pro Human Cytokine 27-plex assay (M500KCAF0Y; Bio-Rad; Kansas City MO) according to the manufacturer’s instructions. During the assay, antibody specifically directed against the cytokine of interest was coupled to a color-coded bead and allowed to incubate with the sample. Then a biotinylated detection antibody was added creating a sandwich of antibodies around the cytokine. This mixture was then detected by streptavidin-PE. When each reaction was run through the bio-plex system the fluorescent intensity was measured and calculated by the Bio-Plex 200 (Bio-Rad; Kansas City MO) software using a standard curve, and data were analyzed in Bio-Plex Data Pro software.
Immunocytochemistry and nuclear staining
Immunocytochemical staining was performed as previously described [21]. Specifically, a mouse monoclonal antibody to nestin (1:100 dilution in PBS/0.5% BSA/0.03% Triton X-100 solution, Millipore; Burlington, MA) was used to label neural stem cells; a mouse monoclonal antibody to polysialic acid neural cell adhesion molecule (PSA-NCAM; 1:500; Miltenyi Biotec Inc; Auburn, CA); and polyclonal antibody to GFAP (1:200, Millipore; Burlington, MA) were used to identify glial cells. Briefly, the cells were rinsed with phosphate-buffered saline (PBS), fixed with ice-cold 4% paraformaldehyde in PBS and permeabilized with 0.5% bovine serum albumin (BSA)/Triton X-100 in PBS for 1 h. The cells were incubated with primary antibody at 4°C overnight. Bound antibodies were revealed with FITC-conjugated sheep anti-mouse IgG second antibody, or rhodamine-conjugated sheep anti-rabbit IgG secondary antibody. DAPI, a nuclear stain dye, in the mounting medium was applied to determine total cell counts in the cultures. Cells were viewed using an Olympus IX71 microscope (Olympus; Center Valley, PA).
Flow cytometry analysis of PSA-NCAM staining
Cultured neural cells were dissociated from culture dishes using Accutase™ Cell Detachment Solution (BD Biosciences; San Jose, CA), washed with PBS, filtered through a 70-µm Falcon® cell strainer (Life Sciences; Tewksbury, MA), fixed in BD Cytofix Fixation buffer (BD Biosciences; San Jose, CA) and permeabilized with BD Phosflow Perm Buffer III (BD Biosciences; San Jose, CA). Non-specific antibody binding was blocked using Human Fc Block (1:300) (catalog #564220, BD Biosciences; San Jose, CA) for 30 min at 4°C in cell staining buffer. Cells were washed and resuspended in PE conjugated PSA-NCAM (1:50) (Miltenyi Biotec Inc; Auburn, CA) for 1 h at room temperature. Samples were washed twice and immediately ran on a BD Bioscience LSR Fortessa flow cytometer. Data were analyzed using FCS Express version 6 (De Novo Software).
Statistical analysis
Statistical analyses were performed, and graphs were produced using GraphPad Prism 9 (GraphPad Software Inc.; San Diego, CA). Data were analyzed with GraphPad Prism 9 using the unpaired t-test, and expressed as mean ± SD. A p-value less than 0.05 was considered statically significant. Each treatment condition was assessed at least in triplicate, and experiments were repeated three times independently.
Results
Characterization of NSCs
The cultured monkey NSCs demonstrated the features of being able to self-renew (Figures 1A-C) and differentiate to generate lineages of neurons as well as glia including astrocytes and oligodendrocytes (Figure 2). As shown in Figure 1, numerous morphologically bipolar monkey NSCs were generated on day in vitro (DIV) 8, and most of these cells were positively stained by a NSC marker, nestin. In this control culture, the NSC proliferation was further confirmed using a commercially available EdU incorporation assay. The merged picture (Figure 1D; nestin/EdU/DAPI) shows that many of nestin-positive NSCs (green) were EdU-positive (red), demonstrating the capability of NSCs to proliferate.
Figure 1. Representative photographs of immunostaining of nestin and EdU incorporation. In this control culture, numerous nestin positive NSCs [(A); green] were EdU-positive [(B); red]. These cells were undifferentiated NSCs when the cultures were maintained in the NSC growth medium. The total number of cells in the culture was revealed by DAPI-labeled nuclei (C), and a merged image (D). Approximately, on the day in vitro 8, the cells are confluent/ready for experiments. Scale bar = 50 µm.
Figure 2. Representative photographs of NSC differentiation. Different neural cells (derived from monkey NSCs) with multiple processes and a clear neural network could be observed when the control cultures were maintained in neural differentiation medium. Morphologically defined neurons were positively stained by a monoclonal antibody to PSA-NCAM [(A); green]. Typical astrocytes were labeled with the anti-GFAP antibody [(B); red]. Scale bar = 50 µm.
Differentiated cells with multiple processes and a clear neural network were observed (Figure 2), when the cultures were maintained in neural differentiation medium for 5 days. Morphologically defined developing neurons were positively stained with specific neuronal marker, PSA-NCAM [A (green)], and typical astrocytes were labeled with the anti-GFAP antibody [B (red)].
Cell cycle
Desflurane did not significantly affect the proportion of NSCs in each phase of the cell cycle, after 3-h (Figure 3A) or 24-h (Figure 3B) exposures, compared with the controls. There was no difference in the number of cells in S phase, indicating desflurane did not alter NSC differentiation. Results are pooled from three independent experiments.
Figure 3. Proportion of cells in each phase of the cell cycle. Monkey NSCs were treated with 5.7% desflurane or delivery mixed air for 3 (A) or 24 (B) hours. Immediately following exposure, cells were collected and treated as described in the methods. Desflurane exposure does not significantly affect the proportion of NSCs in each phase of the cell cycle. Results are pooled from 3 independent experiments; a student’s T-test revealed no statistical significance.
LDH release from NSCs and the differentiated cells
At clinically relevant doses (5.7%), desflurane did not induce significant changes in LDH release, in both short (3 h) term (Figure 4A), and prolonged (24 h) exposure groups (Figure 4B).
Figure 4. To study the vulnerability of NSCs to desflurane-induced neurotoxicity, LDH levels in the culture medium were monitored. No significant changes in the LDH release were detected when the monkey NSCs were exposed to desflurane (5.7%) in both short term (3 h) cultures (A) and prolonged (24 h) cultures (B). The experiments were repeated three times independently.
On the other hand, differentiated cells had a significant elevation in LDH release into the culture medium after 24-h exposure (Figure 5B), however, the 3-h exposure did not show a difference (Figure 5A). (Figure 5 about here)
Figure 5. To study the vulnerability of differentiated neuronal cells to desflurane-induced neurotoxicity, LDH levels in the culture medium were monitored. Differentiated neuronal cell viability was not significantly affected after short term (3 h) desflurane exposure (A). However, a significant elevation in LDH release into the culture medium was observed when these neuronal cells (derived/differentiated from monkey NSCs) were exposed to desflurane (5.7%) for 24 h (B). The experiments were repeated three times independently. *p ≤ 0.05.
Cytokine changes in the differentiated cells
Desflurane exposure resulted in significant increases in levels of the key proinflammatory cytokines: interleukin 12 (IL-12) with an average 1.3-fold increase, G-CSF with an average 1.85-fold increase, TNF-α with an average 1.66-fold increase and anti-inflammatory cytokine such as interleukin 9 (IL-9) with an average 1.25-fold increase and interleukin 10 (IL-10) with an average 2.0-fold increase. These results (summarized in Table 1 and Figure 6) indicate that an enduring increase in systemic inflammatory cytokines may occur after 24-h desflurane exposure.
Table 1. Summary of Cytokines change in differentiated neural cells.
Figure 6. Desflurane induced inflammasome activation was evaluated using the Bio-Plex Pro Human Cytokine 27-plex assay. Prolonged desflurane (24 h) exposure resulted in significantly increased expression levels of multiple cytokines, including G-CSF, IL-12, IL-9, IL-10, and TNF-
Potential toxic effects after prolonged desflurane exposure (24 h) on differentiated neural cells were examined using immunocytochemical markers including neuronal and glial specific antibodies such as PSA-NCAM (neuronal specific marker), GFAP (astrocyte specific marker) and Galc [oligodendrocyte specific markers (data not shown)]. Numerous typical neurons were labeled by PSA-NCAM on their membrane surface of both cell bodies and processes in the control cultures (Figure 7A), and many differentiated astrocytes were labeled with the anti-GFAP antibody [Figure 7B (red)]. The number of PSA-NCAM positive neurons was obviously reduced after desflurane exposure. PSA-NCAM expression in the desflurane group exhibited typically condensed residue pieces, fragmentation and shrinking profiles (Figure 7C) compared with control (Figure 7A). In contrast, GFAP labeled astrocytes were not remarkably affected by desflurane (Figure 7D).
Figure 7. Differentiated neural cells with multiple processes and a clear neural network (cellular interactions facilitated through contact between cellular protrusions) could be observed after 5 days differentiation. Morphologically defined neurons were positively stained with monoclonal PSA-NCAM (neuron specific marker) antibody (A). However, the number of PSA-NCAM positive neurons was obviously reduced in desflurane-exposed (prolonged) cultures. PSA-NCAM expression in desflurane group was exhibiting typically condensed residue pieces, fragmentation and shrinking profiles [(C); green] compared with control [(A); green]. In contrast, GFAP labeled astrocytes were not remarkably affected in the desflurane group [(D); red], compared with control group [(B); red].
Analysis of PSA-NCAM expression by flow cytometry
Desflurane exposure diminished PSA-NCAM expression. Figure 8A shows a representative histogram. The black filled histogram is the unstained control. The light blue striped histograms are the desflurane exposed cells, and the solid dark blue histograms are the control air exposed cells. Figure 8B shows the percentage of single cells expressing PSA-NCAM after exposure to desflurane or control air. The data is pooled from three experiments. The experiments were repeated three times independently. Consistent with the immunocytochemistry data, the flow cytometry analysis (Figure 8) illustrates that 24-h desflurane exposure reduced the number of positively labeled PSA-NCAM cells, suggesting the reduction/damage of the developing neurons.
Figure 8. Representative flow cytometry histogram, normalized to mode, of PSA-NCAM staining. The black filled histogram is the unstained control. The light blue striped histograms are the desflurane exposed cells, and the solid dark blue histograms are the control air (delivery mixed air) exposed cells (A). The percentage of single cells expressing PSA-NCAM after exposure to desflurane or control air is shown (B). Our data indicated that prolonged (24 h) desflurane exposure at clinically relevant concentration specifically resulted in PSA-NCAM diminished expression. The data were pooled from three independent experiments. ***p < 0.0001.
Discussion
NSC culture is a key tool that can be used to assess potential anesthetic-induced neurotoxicity [13, 14]. Here, we used NSCs derived from fetal monkey multipotent stem cells to create a vitro model of the developing nervous system to study the pathophysiology of neurodegeneration associated with anesthetic (such as desflurane)-induced neurotoxicity [28]. Our data demonstrated that cultured monkey NSCs can proliferate on a dish and differentiate into neural cells (including neurons and glial cells). Our data highlights the effectiveness of the nonhuman primate NSC model to study anesthetic (e.g., desflurane)-induced neurotoxicity in the developing CNS.
Links between anesthesia exposure in developing brains and subsequent cognitive deficiencies have been identified in many pre-clinical studies [30–32]. Pre-clinically, both cell-culture and animal studies [11–14, 21] suggest that anesthetics may cause neural apoptosis, caspase activation, neurodegeneration, neuroinflammation, and ultimately, deficits in cognition. Desflurane is not often used for induction of anesthesia in children due to its potent airway irritant properties, which can lead to coughing, laryngospasm, and other complications. However, it can be used for maintaining anesthesia in children. Previously, an animal study in neonatal and adult mice demonstrated that desflurane exposure induced more neural apoptosis in neonatal mice compared to sevoflurane and isoflurane [33]. Further, adult mice exposed to desflurane demonstrated greater impairments in working memory compared to adult mice exposed to sevoflurane and isoflurane. It is important that any potentially deleterious side effects of anesthetics be elucidated and properly addressed. In the present study, the short-term or prolonged exposure of NSCs to a clinically relevant concentration of desflurane did not affect NSC proliferation and viability, suggesting NSCs are not sensitive to anesthetic-induced neurotoxicity. In contrast, the developing neurons were vulnerable to desflurane. The possible reason for the vulnerability may be due to the expression of GABAA receptors on neurons. Our previous data demonstrated that no GABAA receptor immuno-reactive staining was detected on nestin-positive NSCs (lacking physiological activation). However, strong immunoreactive staining for the GABAA receptor was observed on neurons that were differentiated from NSCs [13]. Therefore, after differentiation, prolonged exposure to desflurane caused significant elevation of neuronal cell death and changes in cytokine levels, providing evidence that neuronal cells are a more vulnerable cell population than uncommitted NSCs to anesthetic-induced adverse effects in the developing nervous system.
Numerous preclinical animal studies suggest some evidence of neurotoxicity of volatile anesthetics [30, 34–36]. Moreover, numerous in vivo studies using a variety of models have demonstrated the potential of cognitive/developmental issues in children exposed to early-life anesthesia [35–37]. These concerns are balanced by a risk–benefit analysis. Currently, it is unknown if the in vitro models used here will have similar baseline and cell signaling (molecules) responses to desflurane exposure (short or prolonged) and alter developing neuronal transmission systems in corresponding in vivo models. Previously, neuroleptic anesthesia with a surgical insult (splenectomy) in rats resulted in signs of CNS inflammation and cognitive impairment on the first and third postoperative days, whereas control and anesthesia-only groups showed neither inflammatory changes nor behavioral effects [37]. Also, our previous in vivo studies [22] demonstrated that at a clinically relevant dosage, inhaled anesthetics (e.g., sevoflurane) induced and maintained a stable surgical anesthesia status in postnatal day 5 monkeys, and prolonged sevoflurane exposure resulted in significant alterations in gene expression profiles, cytokine secretion, lipid composition, and neuronal cell death. These data/findings are consistent with the view that prolonged exposure to inhaled agents could stimulate an inflammatory reaction in the CNS, which may contribute to cell death or other lasting negative consequences of early-life exposure to anesthesia.
Cytokines, key modulators of inflammation, are signaling molecules and are produced in response to invading pathogens [38–41]. It is well known that cytokines mediate neuronal and glial cell function to facilitate neuronal regeneration or neurodegeneration, and cytokine dysregulation is linked to microglial activation, neuroinflammation, neuronal damage, and cognitive deficits. In the present study, prolonged desflurane exposure of differentiated neural cells increased levels of multiple cytokines, including G-CSF, IL-12, IL-9, IL-10, and TNF-α, compared with controls. Neuroinflammation could play critical roles in the pathogenesis after longer durations of inhaled anesthetic exposure [22, 42]. Thus, altered cytokines could primarily be responsible for the development of increased neuroinflammation, and subsequent neuronal damage. Our data indicated that an enduring increase in systemic inflammatory cytokines (pro and anti-inflammatory cytokine accumulation) may occur after desflurane exposure. Elevated neurodegeneration after prolonged anesthetic exposure may involve an imbalance of pro- and anti-inflammatory cytokines [37, 42]. Since disturbed proinflammatory cytokines, especially TNF-
It has been reported that exposure to inhaled anesthetics produced transient changes in dendritic spine density in the developing brain [43], which may result in lasting changes to synaptic ultrastructure [44]. Longer durations of inhaled anesthetic exposure could inhibit LTP [45], and prolonged sevoflurane exposure decreased survival of neurons [46]. PSA-NCAM is a specific marker for developing neurons [21, 22]. Ultrastructural studies showed that during early development the polysialylated form of NCAM is expressed by growth cones, neuronal processes, and neuronal bodies [27, 47]. In the current study, substantial downregulation of PSA-NCAM expression was observed on the neuronal surface and their processes in prolonged desflurane-exposed neurons. In contrast, no significant differences including the number, size, form, and distribution of GFAP labeled astrocytes were observed between desflurane-exposed and control (mixed delivery air) cultures. Our flow cytometry analysis provided quantitative information on a reduced number of developing neurons and downregulation of PSA-NCAM expression levels with desflurane (24 h) exposure versus their control. These results highlight that differentiated neurons, not glia, are the most vulnerable cell population to prolonged desflurane-induced toxicity. In fact, PSA-NCAM is of protective interest/effect for its key role in promoting neuritogenesis and synaptic plasticity. Altered PSA-NCAM expression levels could result in significant changes in synaptic activity, synaptic formation, and synaptic remodeling [27, 48, 49], and consequently neuronal damage. Also, synaptic pruning and subsequent neuronal loss, whether by programmed cell death or necrosis, are critical to plasticity and stabilization of circuits in the developing nervous system and these are active processes that are tightly controlled by neurotrophins signaling mechanisms to ensure normal development and facilitate synaptic plasticity [50]. Previously, it was reported that PSA-NCAM interacts with NMDA-type glutamate receptors [51, 52]. PSA-NCAM could prevent glutamate-induced cell death [52] by restraining the signaling through GluN2B-containing NMDA receptors and regulating GluN2B-mediated Ca2+ influx in CA1 pyramidal cells in hippocampal slices [53]. It should be noted that PSA-NCAM may increase the sensitivity of neurons to brain derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) [54]. Also, PSA-NCAM could induce the activation of fibroblast growth fact receptor 1 (FGFR1) [55], and FGFR1/FGFs could critically impact retinal ganglion cells (RGCs; bridging neurons that connect the retinal input to the visual processing centers) survival [56]. Therefore, the dysregulated PSA-NCAM expression, after prolonged desflurane exposure, could suggest: 1) early neurodegeneration, 2) interruption of synaptic communication, 3) functional and/or behavioral deficits, 4) altered neuronal viability and plasticity, and 5) a target molecule in dissecting underlying mechanisms associated with prolonged anesthetic-induced neurotoxicity on uncommitted NSCs and differentiated neuronal cells. Collectively, the present study demonstrated that prolonged desflurane-induced downregulation/shedding of PSA-NCAM was closely related to the observed loss/damage of developing neurons.
It should also be mentioned that the VitroCell system used for toxicological testing of desflurane has some limitations. For example, 1) although temperature and humidity of the test have been conditioned and well controlled to meet specific requirements of the cell cultures, owing to the complexity of the physical processes governing desflurane transport and deposition, the submersed state of a cell culture is not exactly/absolutely representative of the situation in the respiratory tract. And 2) although each treatment condition was assayed at least in triplicate and the experiments were repeated three times independently, toxicological testing of desflurane requires more experimental replicates than three replicates which matters to ensure/facilitate the correct amount of drug was applied to each well and in a reasonably uniform/consistent manner and should be addressed in our future desflurane studies.
Summary
Our findings suggest that at clinically relevant doses (5.7%) desflurane did not result in significant changes in NSC viability and NSC proliferation. In contrast, after differentiation, significantly elevated neuronal damage was detected after prolonged desflurane exposure. Our results indicated that an enduring increase in systemic inflammatory cytokines occurred after desflurane exposure, and the cytokine dysregulation could be a critical contributing factor to prolonged desflurane-induced neurotoxicity. In addition, the changes in PSA-NCAM expression confirmed the vulnerability of neurons in desflurane-induced neurotoxicity. Our experimental analyses provided quantitatively accurate and reproducible information regarding reduced neuronal viability and remarkable attenuation of PSA-NCAM levels after prolonged desflurane exposure.
Future work
Continued pre-clinical investigation may have significant impact on desflurane’s clinical practice. Associated perturbations of the nervous system could be involved in blocking excitatory ion channels and increasing the activity of inhibitory ion channels. Since neural receptors/ion channels and PSA-NCAM expression levels, as well as calcium signaling, play crucial roles in receiving external signals and regulating intracellular signaling in numerous neurological processes, a study to monitor the baseline responsivity to neurotransmitters and changes in intracellular calcium concentrations would be informative for measuring states of cellular activity, neuronal viability and neuronal plasticity associated with anesthetic (desflurane)-induced neurotoxicity.
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Author disclaimer
This document reflects the views of its authors and does not necessarily reflect those of the United States Food and Drug Administration. Any mention of commercial products is for clarification only and is not intended as approval, endorsement, or recommendation.
Data availability
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The animal study was approved by NCTR/FDA Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was funded by the Food and Drug Administration.
Acknowledgments
We would like to thank Dr. Jacqueline Yeary for her assistance in performing cytokine assay/analysis, and Mr. Charles Matthew Fogle for his technical support.
Conflict of interest
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Generative AI statement
The authors declare that no Generative AI was used in the creation of this manuscript.
References
1. Wilder, RT, Flick, RP, Sprung, J, Katusic, SK, Barbaresi, WJ, Mickelson, C, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology (2009) 110:796–804. doi:10.1097/01.anes.0000344728.34332.5d
2. Wei, H, Kang, B, Wei, W, Liang, G, Meng, QC, Li, Y, et al. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res (2005) 1037:139–47. doi:10.1016/j.brainres.2005.01.009
3. Ikonomidou, C, Bosch, F, Miksa, M, Bittigau, P, Vöckler, J, Dikranian, K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science (1999) 283:70–4. doi:10.1126/science.283.5398.70
4. Loepke, AW, Istaphanous, GK, McAuliffe, JJ, Miles, L, Hughes, EA, McCann, JC, et al. The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth and Analgesia (2009) 108:90–104. doi:10.1213/ane.0b013e31818cdb29
5. Satomoto, M, Satoh, Y, Terui, K, Miyao, H, Takishima, K, Ito, M, et al. Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology (2009) 110:628–37. doi:10.1097/aln.0b013e3181974fa2
6. Stratmann, G, May, LD, Sall, JW, Alvi, RS, Bell, JS, Ormerod, BK, et al. Effect of hypercarbia and isoflurane on brain cell death and neurocognitive dysfunction in 7-day-old rats. Anesthesiology (2009) 110:849–61. doi:10.1097/aln.0b013e31819c7140
7. Fredriksson, A, Ponten, E, Gordh, T, and Eriksson, P. Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology (2007) 107:427–36. doi:10.1097/01.anes.0000278892.62305.9c
8. Viberg, H, Ponten, E, Eriksson, P, Gordh, T, and Fredriksson, A. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology (2008) 249:153–9. doi:10.1016/j.tox.2008.04.019
9. O’Leary, JD, Janus, M, Duku, E, Wijeysundera, DN, To, T, Li, P, et al. Influence of surgical procedures and general anesthesia on child development before primary school entry among matched sibling pairs. JAMA Pediatr (2019) 173:29–36. doi:10.1001/jamapediatrics.2018.3662
10. Walkden, GJ, Pickering, AE, and Gill, H. Assessing long-term neurodevelopmental outcome following general anesthesia in early childhood: challenges and opportunities. Anesth and Analgesia (2019) 128:681–94. doi:10.1213/ane.0000000000004052
11. Wang, C, Fridley, J, and Johnson, KM. The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem Pharmacol (2005) 69:1373–83. doi:10.1016/j.bcp.2005.02.013
12. Slikker, W, Zou, X, Hotchkiss, CE, Divine, RL, Sadovova, N, Twaddle, NC, et al. Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci (2007) 98:145–58. doi:10.1093/toxsci/kfm084
13. Liu, F, Patterson, TA, Sadovova, N, Zhang, X, Liu, S, Zou, X, et al. Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol Sci (2013) 131:548–57. doi:10.1093/toxsci/kfs296
14. Liu, F, Rainosek, SW, Sadovova, N, Fogle, CM, Patterson, TA, Hanig, JP, et al. Protective effect of acetyl-l-carnitine on propofol-induced toxicity in embryonic neural stem cells. Neurotoxicology (2014) 42:49–57. doi:10.1016/j.neuro.2014.03.011
15. Paule, MG, Li, M, Allen, RR, Liu, F, Zou, X, Hotchkiss, C, et al. Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicology and Teratology (2011) 33:220–30. doi:10.1016/j.ntt.2011.01.001
16. Talpos, JC, Chelonis, JJ, Li, M, Hanig, JP, and Paule, MG. Early life exposure to extended general anesthesia with isoflurane and nitrous oxide reduces responsivity on a cognitive test battery in the nonhuman primate. Neurotoxicology (2019) 70:80–90. doi:10.1016/j.neuro.2018.11.005
17. Raper, J, De Biasio, JC, Murphy, KL, Alvarado, MC, and Baxter, MG. Persistent alteration in behavioural reactivity to a mild social stressor in rhesus monkeys repeatedly exposed to sevoflurane in infancy. Br J Anaesth (2018) 120:761–7. doi:10.1016/j.bja.2018.01.014
18. Nishikawa, K, and Harrison, NL. The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits. Anesthesiology (2003) 99:678–84. doi:10.1097/00000542-200309000-00024
19. Zou, X, Patterson, TA, Divine, RL, Sadovova, N, Zhang, X, Hanig, JP, et al. Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Developmental Neurosci (2009) 27:727–31. doi:10.1016/j.ijdevneu.2009.06.010
20. Wang, C, Sadovova, N, Fu, X, Schmued, L, Scallet, A, Hanig, J, et al. The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience (2005) 132:967–77. doi:10.1016/j.neuroscience.2005.01.053
21. Wang, C, Sadovova, N, Hotchkiss, C, Fu, X, Scallet, AC, Patterson, TA, et al. Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci (2006) 91:192–201. doi:10.1093/toxsci/kfj144
22. Liu, F, Rainosek, SW, Frisch-Daiello, JL, Patterson, TA, Paule, MG, Slikker, W, et al. Potential adverse effects of prolonged sevoflurane exposure on developing monkey brain: from abnormal lipid metabolism to neuronal damage. Toxicol Sci (2015) 147:562–72. doi:10.1093/toxsci/kfv150
23. Kiss, JZ, and Rougon, G. Cell biology of polysialic acid. Curr Opin Neurobiol (1997) 7:640–6. doi:10.1016/s0959-4388(97)80083-9
24. Rougon, G. Structure, metabolism and cell biology of polysialic acids. Eur J Cell Biol (1993) 61:197–207.
25. Liu, F, Liu, S, Patterson, TA, Fogle, C, Hanig, JP, Wang, C, et al. Protective effects of xenon on propofol-induced neurotoxicity in human neural stem cell-derived models. Mol Neurobiol (2020) 57:200–7. doi:10.1007/s12035-019-01769-5
26. Becker, CG, Artola, A, Gerardy-Schahn, R, Becker, T, Welzl, H, and Schachner, M. The polysialic acid modification of the neural cell adhesion molecule is involved in spatial learning and hippocampal long-term potentiation. J Neurosci Res (1996) 45:143–52. doi:10.1002/(sici)1097-4547(19960715)45:2<143::aid-jnr6>3.3.co;2-y
27. Wang, C, Inselman, A, Liu, S, and Liu, F. Potential mechanisms for phencyclidine/ketamine-induced brain structural alterations and behavioral consequences. Neurotoxicology (2020) 76:213–9. doi:10.1016/j.neuro.2019.12.005
28. Latham, LE, Dobrovolsky, VN, Liu, S, Talpos, JC, Hanig, JP, Slikker, W, et al. Establishment of neural stem cells from fetal monkey brain for neurotoxicity testing. Exp Biol Med (Maywood) (2023) 248:633–40. doi:10.1177/15353702231168145
29. McInnis, J, Wang, C, Anastasio, N, Hultman, M, Ye, Y, Salvemini, D, et al. The role of superoxide and nuclear factor-κb signaling in N-Methyl-d-aspartate-Induced necrosis and apoptosis. The J Pharmacol Exp Ther (2002) 301:478–87. doi:10.1124/jpet.301.2.478
30. Jevtovic-Todorovic, V, Benshoff, N, and Olney, JW. Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol (2000) 130:1692–8. doi:10.1038/sj.bjp.0703479
31. Olney, JW, Wozniak, DF, Jevtovic-Todorovic, V, Farber, NB, Bittigau, P, and Ikonomidou, C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol (2002) 12:488–98. doi:10.1111/j.1750-3639.2002.tb00467.x
32. Olney, JW, Young, C, Wozniak, DF, Jevtovic-Todorovic, V, and Ikonomidou, C. Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci (2004) 25:135–9. doi:10.1016/j.tips.2004.01.002
33. Kodama, M, Satoh, Y, Otsubo, Y, Araki, Y, Yonamine, R, Masui, K, et al. Neonatal desflurane exposure induces more robust neuroapoptosis than do isoflurane and sevoflurane and impairs working memory. Anesthesiology (2011) 115:979–91. doi:10.1097/aln.0b013e318234228b
34. Culley, DJ, Baxter, MG, Crosby, CA, Yukhananov, R, and Crosby, G. Impaired acquisition of spatial memory 2 weeks after isoflurane and isoflurane-nitrous oxide anesthesia in aged rats. Anesth analgesia (2004) 99:1393–7. doi:10.1213/01.ane.0000135408.14319.cc
35. Steinmetz, J, Christensen, KB, Lund, T, Lohse, N, Rasmussen, LS, and Group, I. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology (2009) 110:548–55. doi:10.1097/aln.0b013e318195b569
36. Koblin, DD. Characteristics and implications of desflurane metabolism and toxicity. Anesth Analg (1992) 75:S10–6.
37. Wan, Y, Xu, J, Ma, D, Zeng, Y, Cibelli, M, and Maze, M. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology (2007) 106:436–43. doi:10.1097/00000542-200703000-00007
38. Dickson, DW, Lee, SC, Mattiace, LA, Yen, SH, and Brosnan, C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia (1993) 7:75–83. doi:10.1002/glia.440070113
39. Wilson, CJ, Finch, CE, and Cohen, HJ. Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc (2002) 50:2041–56. doi:10.1046/j.1532-5415.2002.50619.x
40. McGeer, PL, and McGeer, EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev (1995) 21:195–218. doi:10.1016/0165-0173(95)00011-9
41. Wu, X, Lu, Y, Dong, Y, Zhang, G, Zhang, Y, Xu, Z, et al. The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β. Neurobiol Aging (2012) 33:1364–78. doi:10.1016/j.neurobiolaging.2010.11.002
42. Wei, H, Liang, G, Yang, H, Wang, Q, Hawkins, B, Madesh, M, et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology (2008) 108:251–60. doi:10.1097/01.anes.0000299435.59242.0e
43. Qiu, L, Zhu, C, Bodogan, T, Gomez-Galan, M, Zhang, Y, Zhou, K, et al. Acute and long-term effects of brief sevoflurane anesthesia during the early postnatal period in rats. Toxicol Sci (2016) 149:121–33. doi:10.1093/toxsci/kfv219
44. Fehr, T, Janssen, WGM, Park, J, and Baxter, MG. Neonatal exposures to sevoflurane in rhesus monkeys alter synaptic ultrastructure in later life. iScience (2022) 25:105685. doi:10.1016/j.isci.2022.105685
45. Xiao, H, Liu, B, Chen, Y, and Zhang, J. Learning, memory and synaptic plasticity in hippocampus in rats exposed to sevoflurane. Int J Developmental Neurosci (2016) 48:38–49. doi:10.1016/j.ijdevneu.2015.11.001
46. Fang, F, Xue, Z, and Cang, J. Sevoflurane exposure in 7-day-old rats affects neurogenesis, neurodegeneration and neurocognitive function. Neurosci Bull (2012) 28:499–508. doi:10.1007/s12264-012-1260-4
47. Butler, AK, Uryu, K, Morehouse, V, Rougon, G, and Chesselet, MF. Regulation of the polysialylated form of the neural cell adhesion molecule in the developing striatum: effects of cortical lesions. J Comp Neurol (1997) 389:289–308. doi:10.1002/(sici)1096-9861(19971215)389:2<289::aid-cne8>3.0.co;2-y
48. Regan, CM, and Fox, GB. Polysialytation as a regulator of neural plasticity in rodent learning and aging. Neurochem Res (1995) 20:593–8. doi:10.1007/bf01694541
49. Ronn, LC, Hartz, BP, and Bock, E. The neural cell adhesion molecule (NCAM) in development and plasticity of the nervous system. Exp Gerontol (1998) 33:853–64. doi:10.1016/s0531-5565(98)00040-0
50. Perouansky, M, Hemmings, HC, and Riou, B. Neurotoxicity of general anesthetics: cause for concern? Anesthesiology (2009) 111:1365–71. doi:10.1097/aln.0b013e3181bf1d61
51. Bai, N, Aida, T, Yanagisawa, M, Katou, S, Sakimura, K, Mishina, M, et al. NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina. Mol Brain (2013) 6:34. doi:10.1186/1756-6606-6-34
52. Hammond, MS, Sims, C, Parameshwaran, K, Suppiramaniam, V, Schachner, M, and Dityatev, A. Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamate-induced cell death. J Biol Chem (2006) 281:34859–69. doi:10.1074/jbc.m602568200
53. Kochlamazashvili, G, Senkov, O, Grebenyuk, S, Robinson, C, Xiao, MF, Stummeyer, K, et al. Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors. J Neurosci (2010) 30:4171–83. doi:10.1523/jneurosci.5806-09.2010
54. Hildebrandt, H, Muhlenhoff, M, Weinhold, B, and Gerardy-Schahn, R. Dissecting polysialic acid and NCAM functions in brain development. J Neurochem (2007) 103(Suppl. 1):56–64. doi:10.1111/j.1471-4159.2007.04716.x
55. Kiselyov, VV, Skladchikova, G, Hinsby, AM, Jensen, PH, Kulahin, N, Soroka, V, et al. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure (2003) 11:691–701. doi:10.1016/s0969-2126(03)00096-0
Keywords: anesthetics, desflurane,, developing neurons, neural differentiation, neurotoxicity
Citation: Wang C, Latham LE, Liu S, Talpos J, Patterson TA, Hanig JP and Liu F (2025) Assessing potential desflurane-induced neurotoxicity using nonhuman primate neural stem cell models. Exp. Biol. Med. 250:10606. doi: 10.3389/ebm.2025.10606
Received: 28 March 2025; Accepted: 20 May 2025;
Published: 13 June 2025.
Copyright © 2025 Wang, Latham, Liu, Talpos, Patterson, Hanig and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cheng Wang, Y2hlbmcud2FuZ0BmZGEuaGhzLmdvdg==